tyrosine has been researched along with sea 0400 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ago, Y; Cong, Y; Kawasaki, T; Kitamoto, M; Matsuda, T; Nashida, T; Ota, Y; Takahashi, T; Takuma, K | 1 |
1 other study(ies) available for tyrosine and sea 0400
Article | Year |
---|---|
SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Aniline Compounds; Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Gene Expression Regulation; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Phenyl Ethers; Phosphorylation; Rotarod Performance Test; Sodium-Calcium Exchanger; Time Factors; Tyrosine; Tyrosine 3-Monooxygenase | 2011 |